Skip to main content
Clinical Trials/NCT06909370
NCT06909370CompletedNot Applicable

The Effect of Peer Education for Human Papilloma Virus (HPV) on Knowledge, Awareness and Concern Levels of Students in the Faculty of Health Sciences

Saglik Bilimleri Universitesi1 site in 1 country127 target enrollmentStarted: May 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
127
Locations
1
Primary Endpoint
Sociodemographic Characteristics Form

Study Overview

Brief Summary

According to the World Health Organization (WHO), 400 million treatable sexually transmitted diseases (STDs) such as syphilis, chlamydia and human papillomavirus (HPV) occur each year in people aged 15-49, mostly in developing countries. As HPV is a sexually transmitted virus, it has been shown to be the most important aetiological factor in cervical cancer in women (99.7%). Vaccination and education of young people about sexuality and STDs are very important in the prevention of HPV. In this respect, the aim of this study was to find out the level of knowledge, concern and awareness of HPV infection among university students and to increase their awareness by informing them about the subject through their peers. The study was conducted as a pre-test and post-test one-group study. The sample of the study consisted of all final year students of Physiotherapy and Rehabilitation (85 students), Nutrition and Dietetics (60 students), Audiology (35 students), Child Development (80 students), Health Management (44 students) and Social Work (45 students) studying in the spring semester of the 2023-2024 academic year. The students were trained by the Gynaecology Nursing Intern student group (9 students) of the Department of Nursing. Data were collected using the Sociodemographic Characteristics Form, the HPV Knowledge Scale and the Human Papilloma Virus Awareness and Concern Level Scale (HPV-FAS). The relevant forms and the consent form were completed by the students before, after and one month after the training.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •All individuals who are senior students in the Faculty of Health Sciences departments and who agree to participate in the study will be included in the study.

Exclusion Criteria

  • •Individuals who did not complete the study and did not speak and understand Turkish were excluded from the study.

Arms & Interventions

Sleep Hygiene Training

Experimental

Intervention: peer education (Behavioral)

Outcomes

Primary Outcomes

Sociodemographic Characteristics Form

Time Frame: Through study completion, an average of 6 months

It consists of nine questions containing sociodemographic data of students, developed by the researchers.

HPV Knowledge Scale (HPV-KS)

Time Frame: Through study completion, an average of 6 months

The HPV-KS was developed in 2013 by Waller and colleagues to measure individuals' knowledge levels about HPV, the HPV vaccine, and screening tests. The scale examines whether individuals have previously heard about HPV, the HPV vaccine, and HPV screening tests, as well as the extent of their knowledge on these topics. The first subdimension of the HPV-KS consists of 16 items and assesses participants' general knowledge about HPV. The second subdimension includes six items and is related to HPV screening tests. The third subdimension consists of seven items and asks participants to respond to items about the HPV vaccine. The independent subdimension of the HPV-KS has been developed in three different forms for the HPV vaccination program conducted in three different countries. For each item in the HPV-KS, participants are expected to mark "Yes," "No," or "I don't know." The total score obtained from the HPV-KS ranges from 0 to 33.

Human Papillomavirus Awareness and Concern Scale (HPV-ACS)

Time Frame: Through study completion, an average of 6 months

Developed by Yılmaz Esencan and colleagues (2023), this scale is designed as a five-point Likert-type and consists of 19 items and three subdimensions. The subdimensions of the scale are "Concern about health," "Concern about being excluded," and "Awareness." The scale scores range from a minimum of 0 to a maximum of 76 points. A higher total score indicates a stronger awareness of HPV. The Cronbach's Alpha reliability coefficient of the original scale was determined to be 0.905.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Beyzanur İşbay Aydemir

Lecturer

Istanbul Aydın University

Study Sites (1)

Loading locations...

Similar Trials

Peer Education on HPV: Impact on Health... | Clinical Trial